Abstract
Background: Pseudomyxoma peritonei (PMP), is a rare cancer of the peritoneum. Primary tumor, as it develops in the lumen of the appendix, would clog the appendix and lead to an accumulation of mucus, which would lead to the rupture of the appendix in the peritoneum cavity. This origin then raises the hypothesis of a bacterial component associated with tumor cells. In addition, many vessels are found in this disease. These two components have led our unit to explore the effect of antibiotics and anti-angiogenic combination drugs on the development of PMP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
